Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Characterization of multivalent complexes formed in the presence of more than one conventional antibody to terminal complement component C5.
Journal: PloS one
Published: August 16, 2022
Development, Characterization, and in vivo Validation of a Humanized C6 Monoclonal Antibody that Inhibits the Membrane Attack Complex.
Journal: Journal of innate immunity
Published: January 20, 2022
Complement activity is regulated in C3 glomerulopathy by IgG-factor H fusion proteins with and without properdin targeting domains.
Journal: Kidney international
Published: April 17, 2020
A high density CHO-S transient transfection system: Comparison of ExpiCHO and Expi293.
Journal: Protein expression and purification
Published: January 26, 2017
Complement system activation contributes to the ependymal damage induced by microbial neuraminidase.
Complement system activation contributes to the ependymal damage induced by microbial neuraminidase.
Journal: Journal of neuroinflammation
Published: March 24, 2016
Structural Basis for Eculizumab-Mediated Inhibition of the Complement Terminal Pathway.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: February 18, 2016
Connecting the innate and adaptive immune responses in mouse choroidal neovascularization via the anaphylatoxin C5a and γδT-cells.
Journal: Scientific reports
Published: October 30, 2015
Site-targeted complement inhibition by a complement receptor 2-conjugated inhibitor (mTT30) ameliorates post-injury neuropathology in mouse brains.
Journal: Neuroscience letters
Published: October 25, 2015
Last Updated: 09/26/2026